Asset Details
Do you wish to reserve the book?
Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency
Do you wish to request the book?
Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency
2021
Overview
Mevalonate kinase deficiency (MKD) is an autoinflammatory metabolic disorder characterized by life-long recurring episodes of fever and inflammation, often without clear cause. MKD is caused by bi-allelic pathogenic variants in the MVK gene, resulting in a decreased activity of the encoded enzyme mevalonate kinase (MK). MK is an essential enzyme in the isoprenoid biosynthesis pathway, which generates both non-sterol and sterol isoprenoids. The inflammatory symptoms of patients with MKD point to a major role for isoprenoids in the regulation of the innate immune system. In particular a temporary shortage of the non-sterol isoprenoid geranylgeranyl pyrophosphate (GGPP) is increasingly linked with inflammation in MKD. The shortage of GGPP compromises protein prenylation, which is thought to be one of the main causes leading to the inflammatory episodes in MKD. In this review, we discuss current views and the state of knowledge of the pathogenetic mechanisms in MKD, with particular focus on the role of compromised protein prenylation.
Publisher
Frontiers Media SA,Frontiers Media S.A
Subject
/ Carbon
/ Disease
/ Enzymes
/ Fever
/ Humans
/ Kinases
/ mevalonate kinase deficiency (MKD)
/ Mevalonate Kinase Deficiency - diagnosis
/ Mevalonate Kinase Deficiency - drug therapy
/ Mevalonate Kinase Deficiency - genetics
/ Mevalonate Kinase Deficiency - metabolism
/ Protein Prenylation - genetics
/ Proteins
/ Steroids
/ Sterols
/ Terpenes
